Literature DB >> 8349138

Recognition of oxidized DNA bases by sera of patients with inflammatory diseases.

K Frenkel1, J Karkoszka, E Kim, E Taioli.   

Abstract

Chronic inflammatory conditions result from or contribute to many diseases. Prominent among them is systemic lupus erythematosus (SLE). Sera of SLE patients contain an array of various auto-antibodies (Ab), including antinuclear Ab of unknown etiologies. The most puzzling is formation of Ab directed against autologous DNA. Our hypothesis was that increased oxidant production causes oxidation of DNA bases, which provide antigenic determinants that elicit antioxidized DNA Ab. To test this hypothesis, we used oxidized DNA nucleoside (5-hydroxymethyl-2'-deoxyuridine [HMdU]) conjugated to bovine serum albumin (HMdU-BSA) as the antigen. The results of the enzyme-linked immunosorbent assay showed that these Abs are sensitively detectable in SLE sera and sera of various other inflammatory autoimmune diseases. The titers of anti-HMdU Ab were significantly higher (p < .01) than those present in the control sera. Anti-HMdU Ab were predominantly of the IgM isotype, with low levels of IgG and no IgA. Anti-HMdU Ab bound to the HMdU-BSA-coated wells in a concentration- and time-dependent manner. That binding was inhibited by HMdU-BSA and to a lesser extent by thymidine-BSA, a normal nucleoside conjugate. The specific binding appears to be inversely related to the age of the patients, but no significant differences were observed between the sexes of the same age.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349138     DOI: 10.1016/0891-5849(93)90105-4

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

1.  Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus.

Authors:  M M Freemer; T E King; L A Criswell
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

2.  Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.

Authors:  S Hörkkö; E Miller; E Dudl; P Reaven; L K Curtiss; N J Zvaifler; R Terkeltaub; S S Pierangeli; D W Branch; W Palinski; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Reliability of serum assays of iron status in postmenopausal women.

Authors:  Anne Zeleniuch-Jacquotte; Qi Zhang; Jisen Dai; Roy E Shore; Alan A Arslan; Karen L Koenig; Jerzy Karkoszka; Yelena Afanasyeva; Krystyna Frenkel; Paolo Toniolo; Xi Huang
Journal:  Ann Epidemiol       Date:  2006-10-05       Impact factor: 3.797

4.  Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response?

Authors:  Erin M Siegel; Nitin Patel; Beibei Lu; Ji-Hyun Lee; Alan G Nyitray; Neal E Craft; Krystyna Frenkel; Luisa L Villa; Eduardo L Franco; Anna R Giuliano
Journal:  Int J Cancer       Date:  2011-11-28       Impact factor: 7.396

5.  Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides.

Authors:  A Amara; J Constans; C Chaugier; A Sebban; L Dubourg; E Peuchant; J L Pellegrin; B Leng; C Conri; M Geffard
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

6.  Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uracil.

Authors:  I Kato; J H Vogelman; V Dilman; J Karkoszka; K Frenkel; N P Durr; N Orentreich; P Toniolo
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

7.  Application of reliability models to studies of biomarker validation.

Authors:  E Taioli; P Kinney; A Zhitkovich; H Fulton; V Voitkun; G Cosma; K Frenkel; P Toniolo; S Garte; M Costa
Journal:  Environ Health Perspect       Date:  1994-03       Impact factor: 9.031

8.  Occupational exposures to Cd, Ni, and Cr modulate titers of antioxidized DNA base autoantibodies.

Authors:  K Frenkel; J Karkoszka; B Cohen; B Barański; M Jakubowski; G Cosma; E Taioli; P Toniolo
Journal:  Environ Health Perspect       Date:  1994-09       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.